Mahaling said Odisha is emerging as a hub for innovation and investment in the health sector.
The minister stated that the state government has introduced the Odisha Biotechnology Policy 2024 to prioritize both basic and applied research, as well as technological innovation, by fostering collaboration between industry, academia, and society.
Describing Odisha as a rising hub of innovation and investment, he emphasized the state's focus on expanding super-specialty hospitals, multi-disciplinary healthcare facilities, and the indigenous production of affordable medicines, vaccines, and medical devices.
During a panel discussion on "Skilling in the Health Sector for Utkarsh Odisha – 2036," experts discussed strategies to position Odisha as a leading state in healthcare, pharmaceuticals, and biotechnology.
Mahaling highlighted Odisha’s significant strides in medical education, with 12 functional medical colleges and two more in the pipeline. Additionally, he noted that eight nursing colleges are currently operational, with seven more under development.
The minister also claimed that Odisha is among the few states offering dialysis services at sub-divisional hospitals and populous community health centers (CHCs).
Furthermore, he announced that the state plans to recruit 5,000 doctors and 1,200 nurses to strengthen the healthcare workforce.
The nine pharmaceutical and biotechnology companies that have shown interest in investing in the state are:
Indo European Heart Hospitals and Research Institute Pvt. Ltd, Indo European Research and Healthcare Pvt. Ltd., Monad Life Solutions Pvt. Ltd, Gloport Photonix Innovations Pvt. Ltd., Vikash Residential Institutions Pvt. Ltd., Emsurg Group of Companies, Onlyhealth Pvt. Ltd, .J-VPD Diagnostics Pvt. Ltd and SUM Odisha
According to UNI, Mahaling stated that these investments will accelerate Odisha’s progress in modern healthcare, pharmaceutical, and biotech manufacturing, aligning with the vision of Vikashit Odisha 2036.
With a strong policy framework, infrastructure expansion, and a favorable investment climate, Odisha is well on its way to becoming a national leader in healthcare and biotechnology, the minister asserted.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.